Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSIRIS: Insulin Glulisine Strategies in T2DM
NCT00174642Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2004
- Primary completion
- Dec 2008
- Modality
- Peptides
- Countries
- 18
01
Overview
A Phase 3 trial of insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Dec 2004; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00174642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174642.